Synthesis of N-(Methoxycarbonylthienylmethyl)thioureas and evaluation of their interaction with inducible and neuronal nitric oxide synthase

Molecules

Volumn 15, Issue 5, 2010, Pages 3121-3134

  Suaifan, Ghadeer A R Y ^a   Goodyer, Claire L M ^b   Threadgill, Michael D ^b  

^a UNIVERSITY OF JORDAN   (Jordan)

^b University of Bath   (United Kingdom)

Author keywords

INOS; Mienylmethylthioureas; Nitric oxide synthase; Stimulation

Indexed keywords

DRUG DERIVATIVE; INDUCIBLE NITRIC OXIDE SYNTHASE; NEURONAL NITRIC OXIDE SYNTHASE; THIOPHENE DERIVATIVE; THIOUREA;

ARTICLE; CHEMISTRY; DRUG EFFECT; HUMAN; ISOMERISM; SYNTHESIS; TECHNIQUE; ANALOGS AND DERIVATIVES; DRUG EFFECTS; PROCEDURES;

HUMANS; ISOMERISM; METHODS; NITRIC OXIDE SYNTHASE TYPE I; NITRIC OXIDE SYNTHASE TYPE II; THIOPHENES; THIOUREA;

EID: 77952831887     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules15053121     Document Type: Article

References (25)

1. Napoli, C.; de Nigris, F.; Williams-Ignarro, S.; Pignalosa, O.; Sica, V.; Ignarro, L.J. Nitric Oxide and atherosclerosis: An update. Nitric Oxide 2006, 15, 265-279.
2. Napoli, C.; Ignarro, L.J. Nitric oxide and atherosclerosis. Nitric Oxide 2001, 5, 88-97.
3. Gatto, E.M.; Riobo, N.A.; Carreras, M.C.; Chernavsky, A.; Rubio, A.; Satz, M.L.; Poderoso, J.J. Overexpression of neutrophil neuronal nitric oxide synthase in Parkinson's Disease. Nitric Oxide 2000, 4, 534-539.
4. Lechner, M.; Lirk, P.; Rieder, J. Inducible nitric oxide synthase (iNOS) in tumor biology: The two sides of the same coin. Seminars Cancer Biol. 2005, 75, 277-289.
5. McDaniel, M.L.; Kwon, G.; Hill, J.R.; Marshall, C.A.; Corbett, J.A. Cytokines and nitric oxide in islet inflammation and diabetes. Proc. Soc. Exp. Biol. Med. 1996, 277, 24-32.
6. McCall, T.B.; Feelisch, M.; Palmer, R.M.J.; Moncada, S. Identification of N-iminoethyl-L- ornithine as an irreversible inhibitor of nitric oxide synthase in phagocytic cells. Br. J. Pharmacol. 1991, 702, 234-238
7. Griffith, O.W.; Kilbourn, R.G. Nitric Oxide Synthase inhibitors: Amino acids. Methods Enzymol. 1996, 268, 375-392.
8. Tinker, A.C.; Beaton, H.C.; Boughton-Smith, N.; Cook, T.R.; Cooper, S.L.; Fraser-Rae, L.; Hallam, K.; Hamley, P.; Mclnally, T.; Nicholls, D.J.; Pimm, A.D.; Wallace, A.V. 1,2-Dihydro-4- quinazolinamines: Potent, highly selective inhibitors of inducible nitric oxide synthase which show antiinflammatory activity in vivo. J. Med. Chem. 2003, 46, 913-916.
9. Webber, R.K.; Metz, S.; Moore, W.M.; Connor, J.R.; Currie, M.G.; Fok K.F.; Hagen, T.J.; Hansen, D.W.; Jerome, G.M.; Manning, P.T.; Pitzele, B.S.; Toth, M.V.; Trivedi, M.; Zupec, M.E.; Tjoeng, F.S. Substituted 2-iminopiperidines as inhibitors of human nitric oxide synthase isoforms. J. Med. Chem. 1998, 47, 96-101. (Pubitemid 28070470)
10. Garvey, E.P.; Oplinger, J.A.; Furfine, E.S.; Kiff, R.J.; Laszlo, F.; Whittle, B.J.R.; Knowles, R.G. 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo. J. Biol. Chem. 1997, 272, 4959-4963.
11. Collins, J.L.; Shearer, B.G.; Oplinger, J.A.; Lee, S.; Garvey, E.P.; Salter, M.; Duffy, C.; Burnette, T.C.; Furfine, E.S. N-Phenylamidines as selective inhibitors of human neuronal nitric oxide synthase: Structure-activity studies and demonstration of in vivo activity. J. Med. Chem. 1998, 47, 2858-2871.
12. Goodyer, C.L.M.; Chinje, E.C.; Jaffar, M.; Stratford, I.J.; Threadgill, M.D. Synthesis of N-benzyl- and N-phenyl-2-amino-4,5-dihydrothiazoles and thioureas and evaluation as modulators of the isoforms of nitric oxide synthase. Bioorg. Med. Chem. 2003, 77, 4189-4206.
13. Ulhaq, S.; Chinje, E.C.; Naylor, M.A.; Jaffar, M.; Stratford, I.J.; Threadgill, M.D. Heterocyclic analogues of L-citrulline as inhibitors of the isoforms of nitric oxide synthase (NOS) and identification of Nδ-(4,5-dihydrothiazol-2-yl)ornithine as a potent inhibitor. Bioorg. Med. Chem. 1999, 7, 1787-1796.
14. Goodyer, C.L.M.; Chinje, E.C.; Jaffar, M.; Stratford, I.J.; Threadgill, M.D. Time-dependence and preliminary SAR studies in inhibition of nitric oxide synthase isoforms by homologues of thiocitrulline. Bioorg. Med. Chem. Lett. 2003, 73, 3679-3680.
15. Bock, H.; Roth, B. Radical ions. 49. Redox reactions of some thiophene derivatives. Phosphor. Sulfur Silicon 1983, 14, 211-224.
16. Ulhaq, S.; Chinje, E.C.; Naylor, M.A.; Jaffar, M.; Stratford, I.J.; Threadgill, M.D. S-2-amino-5- azolylpentanoic acids related to L-ornithine as inhibitors of the isoforms of nitric oxide synthase (NOS). Bioorg. Med. Chem. 1998, 6, 2139-2149.
17. Beaton, H.; Boughton-Smith, N.; Hamley, P.; Ghelani, A.; Nicholls, D.J.; Tinker, A.C.; Wallace, A.V. Thienopyridines: Nitric oxide synthase inhibitors with potent in vivo activity. Bioorg. Med. Chem. Lett. 2001, 11, 1027-1030.
18. Ogden, J.E.; Moore, P.K. Inhibition of nitric oxide synthase potential for a novel class of therapeutic agent? Trends Biotechnol. 1995, 13, 70-78
19. Mansuy, D.; Boucher, J.-L. Alternative nitric oxide-producing substrates for NO synthases. Free Radical Biol. Med. 2004, 37, 1105-1121.
20. Lefèvre-Groboillot, D.; Boucher, J.-L.; Mansuy, D.; Stuehr, D.J. Reactivity of the heme-dioxygen complex of the inducible nitric oxide synthase in the presence of alternative substrates. FEBS J. 2006, 273, 180-191.
21. Cai, T.B.; Lu, D.N.; Wang, P.G. N-Hydroxyguanidines as substrates of nitric oxide synthases. Curr. Topics Med. Chem. 2005, 5, 21-36.
22. Zhu, Y.; Nikolic, D.; van Breemen, R.B.; Silverman, R.B. Mechanism of Inactivation of Inducible Nitric Oxide Synthase by Amidine. Irreversible enzyme inactivation without inactivator modification. J. Am. Chem. Soc. 2005, 127, 858-868.
23. Muzaffar, S.; Shukla, N.; Jeremy, J.Y. Nicotinamide adenine dinucleotide phosphate oxidase: A promiscuous therapeutic target for cardiovascular drugs? Trends Cardiovasc. Med. 2005, 15, 278-282.
24. Shukla, N.; Jones, R.; Persad, R.; Angelini, G.D.; Jeremy, J.Y. Effect of sildenafil citrate and a nitric oxide donating sildenafil derivative, NCX 911, on cavernosal relaxation and superoxide formation in hypercholesterolaemic rabbits. Eur. J. Pharmacol. 2005, 517, 224-231.
25. Muzaffar, S.; Shukla, N.; Srivastava, A.; Angelini, G.D.; Jeremy, J.Y. Sildenafil citrate and sildenafil nitrate (NCX 911) are potent inhibitors of superoxide formation and gp91(phox) expression in porcine pulmonary artery endothelial cells. Br. J. Pharmacol. 2005, 146, 109-117.